Quantum Leaps, Microeconomics, and the Treatment of Patients With Hepatitis C and HIV Coinfection

• Autores: Michael S. Saag
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 312, Nº. 4, 2014, págs. 347-348
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Until very recently, patients with hepatitis C virus (HCV) infection were treated with pegylated-interferon administered weekly by subcutaneous injection plus ribavirin given orally twice daily. Over the last decade, however, by virtue of development of directly acting agents, therapy for hepatitis C infection has advanced by several orders of magnitude, creating a transformative and unprecedented revolution.